Irreversible inhibition of aspartate aminotransferase by 2-amino-3-butenoic acid.
D000475:Alkenes / Q000378:metabolism / Q000494:pharmacology; D000613:Aminobutyrates / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D001051:Apoenzymes / Q000037:antagonists & inhibitors; D001219:Aspartate Aminotransferases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D001665:Binding Sites; D002250:Carbon Radioisotopes; D003593:Cytoplasm / Q000201:enzymology; D008956:Models, Chemical; D009206:Myocardium / Q000201:enzymology; D011730:Pyridoxal / Q000037:antagonists & inhibitors; D011733:Pyridoxamine / Q000037:antagonists & inhibitors; D013056:Spectrophotometry, Ultraviolet; D013329:Structure-Activity Relationship; D013552:Swine
D000475:Alkenes; D000613:Aminobutyrates; D001051:Apoenzymes; D002250:Carbon Radioisotopes; D011730:Pyridoxal; D011733:Pyridoxamine; D001219:Aspartate Aminotransferases